Results 101 to 110 of about 4,083,225 (263)
Background Whether use of high‐intensity statins is more important than achieving low‐density lipoprotein cholesterol (LDL‐C) target remains controversial in patients with coronary artery disease.
Juwon Kim +11 more
doaj +1 more source
Objective Whether a low-density lipoprotein cholesterol (LDL-C) goal is essential in secondary prevention is still being debated. The aim of our study was to investigate whether achieving particular LDL-C level goals is associated with the reduction in ...
Yen-Ting Yeh +7 more
semanticscholar +1 more source
ABSTRACT The identification of the “culprit lesion” in acute coronary syndromes (ACS) traditionally relies on coronary angiography, assuming that the most severe stenosis, abrupt occlusion, or largest filling defect marks the site of plaque destabilization.
Fernando Quevedo‐Candela +7 more
wiley +1 more source
ObjectiveThis study aimed to evaluate the current prescribing patterns of statin therapy among outpatients with type 2 diabetes at Friendship Hospital, with a focus on alignment between treatment intensity with cardiovascular risk factors.MethodsA ...
Long Bui +8 more
doaj +1 more source
Ezetimibe and the risk of new-onset type 2 diabetes: a systematic review and meta-analysis
Background Statins reduce cardiovascular risk but may increase new-onset type 2 diabetes mellitus (NO-T2DM). Ezetimibe, a cholesterol absorption inhibitor, is often added to statins to improve lipid control, yet its impact on NO-T2DM remains uncertain ...
Areej S. Albawa’neh +6 more
doaj +1 more source
CONTEXT Low-density lipoprotein cholesterol (LDL-C)-lowering therapy is considerably important in preventing cardiovascular disease (CVD) among patients with diabetes.
So Young Park +5 more
semanticscholar +1 more source
Importance: In phase 2 studies, evolocumab, a fully human monoclonal antibody to PCSK9, reduced LDL-C levels in patients receiving statin therapy. Objective: To evaluate the efficacy and tolerability of evolocumab when used in combination with a ...
유승찬 +10 more
core +1 more source
Intravascular Lithotripsy in Left Main Stem Percutaneous Coronary Intervention
ABSTRACT Background IVL is increasingly used for coronary calcium modification; however, prospective data for its use in LMS lesions are lacking. Aims To evaluate the feasibility, safety, and mechanical efficacy of intravascular lithotripsy (IVL) for calcium modification in calcified distal left main stem (LMS) percutaneous coronary intervention ...
Claudia S Cosgrove +14 more
wiley +1 more source
Supplemental material, sj-docx-1-eso-10.1177_23969873231193288 for High-intensity versus moderate-intensity statin treatment for patients with ischemic stroke: Nationwide cohort study by Frederikke Bach, Nils Skajaa, Buket Öztürk Esen, Cecilia Hvitfeldt ...
Erzsébet Horváth-Puhó (3772324) +6 more
core +1 more source
ABSTRACT Background Coronary pressure pullback characterizes both the overall physiological severity and longitudinal distribution of coronary artery disease. However, the respective relationships of physiological disease severity and longitudinal disease distribution with local and vessel‐wide plaque phenotypes remain incompletely understood.
Takeshi Nishi +9 more
wiley +1 more source

